Literature DB >> 8406591

Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae.

P Rainard1.   

Abstract

The ability of lactoferrin (Lf) bound to Streptococcus agalactiae to interfere with the deposition of complement components on the bacterial surface was investigated by enzyme-linked immunosorbent assay (ELISA). By using a strain of S. agalactiae which activates the alternative pathway of complement in the absence of antibodies, it was found that pretreatment of bacteria with Lf shortened the lag phase preceding the deposition of C3 on bacteria. The kinetics of C3 deposition was comparable to that obtained by adding antibodies against S. agalactiae to agammaglobulinaemic precolostral calf serum (PCS) heated at 56 degrees for 3 min to inactivate the alternative pathway. Accelerated C3 deposition did not occur in the absence of Ca2+ ions. Deposition of C4 on bacteria occurred only when either antibodies or Lf were added to PCS. These results demonstrate that the interaction of lactoferrin with bacteria activated the classical pathway of complement in the absence of antibodies. The binding of purified C1q to bacteria was promoted in a dose-dependent manner by Lf, suggesting that recruitment of classical pathway of complement resulted from the interaction of C1q with Lf adsorbed to the bacterial surface. Phagocytosis of bacteria opsonized with heated PCS (at 56 degrees for 3 min) and Lf was comparable to that occurring in the presence of heated PCS and antibodies. In conclusion, Lf was able to substitute for antibodies in order to activate the classical pathway of complement and to opsonize unencapsulated S. agalactiae efficiently.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406591      PMCID: PMC1421935     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Association of lactoferrin with other proteins, as demonstrated by changes in electrophoretic mobility.

Authors:  A Hekman
Journal:  Biochim Biophys Acta       Date:  1971-12-28

2.  Metal-combining properties of human lactoferrin (red milk protein). 1. The involvement of bicarbonate in the reaction.

Authors:  P L Masson; J F Heremans
Journal:  Eur J Biochem       Date:  1968-12-05

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Structural studies on bovine lactoferrin.

Authors:  F J Castellino; W W Fish; K G Mann
Journal:  J Biol Chem       Date:  1970-09-10       Impact factor: 5.157

5.  Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies.

Authors:  K Yonemasu; R M Stroud
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

6.  Identification of the transferrin- and lactoferrin-binding proteins in Haemophilus influenzae.

Authors:  A B Schryvers
Journal:  J Med Microbiol       Date:  1989-06       Impact factor: 2.472

7.  Bovine lactoferrin receptors in Staphylococcus aureus isolated from bovine mastitis.

Authors:  A S Naidu; M Andersson; J Miedzobrodzki; A Forsgren; J L Watts
Journal:  J Dairy Sci       Date:  1991-04       Impact factor: 4.034

8.  Protein X of Streptococcus agalactiae induces opsonic antibodies in cows.

Authors:  P Rainard; Y Lautrou; P Sarradin; B Poutrel
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

9.  Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharide.

Authors:  P Rainard; C Boulard
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

10.  Binding of bovine lactoferrin to Streptococcus agalactiae.

Authors:  P Rainard
Journal:  FEMS Microbiol Lett       Date:  1992-11-01       Impact factor: 2.742

View more
  9 in total

1.  Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.

Authors:  Bing Ren; Alexander J Szalai; Orlanda Thomas; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

2.  Characterization of binding of human lactoferrin to pneumococcal surface protein A.

Authors:  A Håkansson; H Roche; S Mirza; L S McDaniel; A Brooks-Walter; D E Briles
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  Deposition of complement components on Streptococcus agalactiae in bovine milk in the absence of inflammation.

Authors:  P Rainard; B Poutrel
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

4.  Single nucleotide polymorphisms, haplotypes and combined genotypes of lactoferrin gene and their associations with mastitis in Chinese Holstein cattle.

Authors:  Jinming Huang; Hongmei Wang; Changfa Wang; Jianbin Li; Qiuling Li; Minghai Hou; Jifeng Zhong
Journal:  Mol Biol Rep       Date:  2009-08-12       Impact factor: 2.316

5.  In vitro susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lactoferrin and xylitol.

Authors:  Mary Cloud B Ammons; Loren S Ward; Steve T Fisher; Randall D Wolcott; Garth A James
Journal:  Int J Antimicrob Agents       Date:  2008-11-01       Impact factor: 5.283

Review 6.  Lactoferrin: A Critical Mediator of Both Host Immune Response and Antimicrobial Activity in Response to Streptococcal Infections.

Authors:  Jacky Lu; Jamisha Francis; Ryan S Doster; Kathryn P Haley; Kelly M Craft; Rebecca E Moore; Schuyler A Chambers; David M Aronoff; Kevin Osteen; Steven M Damo; Shannon Manning; Steven D Townsend; Jennifer A Gaddy
Journal:  ACS Infect Dis       Date:  2020-05-07       Impact factor: 5.578

7.  Group B Streptococcus Induces Neutrophil Recruitment to Gestational Tissues and Elaboration of Extracellular Traps and Nutritional Immunity.

Authors:  Vishesh Kothary; Ryan S Doster; Lisa M Rogers; Leslie A Kirk; Kelli L Boyd; Joann Romano-Keeler; Kathryn P Haley; Shannon D Manning; David M Aronoff; Jennifer A Gaddy
Journal:  Front Cell Infect Microbiol       Date:  2017-02-03       Impact factor: 5.293

Review 8.  Lactoferrin in a Context of Inflammation-Induced Pathology.

Authors:  Marian L Kruzel; Michal Zimecki; Jeffrey K Actor
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

Review 9.  Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics.

Authors:  Jack Mellors; Tom Tipton; Stephanie Longet; Miles Carroll
Journal:  Front Immunol       Date:  2020-07-09       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.